AI Platform 2.2 (AIP002)— 510(k) K260217
Substantially EquivalentExo Imaging
FDA 510(k) clearance K260217 for AI Platform 2.2 (AIP002), Substantially Equivalent on 2026-02-24. Applicant: Exo Imaging.
Clearance details
- Applicant
- Exo Imaging
- Product code
- Code QIH
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Santa Clara, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.